Physician

David Moaddel, M.D.

According to 2025 Medicare claims, David Moaddel, M.D. (NPI: 1376808626) practices family practice in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is MOADDEL MEDICAL CORPORATION (NPI: 1780371799; TIN: 874817476) and primary practice location at 91307-4001. Moaddel is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), participating under the MSSP model.

Moaddel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 722 traditional Medicare patients, billed 5,405 HCPCS/CPT codes, and received $2,203,934 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 1,238 prescription claims across 250 beneficiaries totaling $79,301 in drug costs, led by Eliquis (Apixaban). DME data shows 13 claims. Open Payments data shows 5 records totaling $201. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,642 to $2,203,934. Similarly, Part D prescription costs have moved sharply higher in recent years, from $38,948 to $79,301. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $287 to $9,335.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	104	209	$16,642
2018	488	1,116	$101,564
2019	476	969	$88,667
2020	441	963	$89,425
2021	299	908	$77,799
2022	443	2,072	$261,492
2023	628	4,401	$801,475
2024	722	5,405	$2,203,934

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	78	814	$38,948
2016	96	847	$29,976
2017	121	693	$31,977
2018	118	288	$23,369
2019	134	270	$20,423
2020	155	277	$16,309
2021	146	307	$26,368
2022	120	282	$14,043
2023	161	389	$31,619
2024	250	1,238	$79,301

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$154
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	29	$1,434
2024	N/R	13	$51

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	171	171	$149
11042	Removal of skin and tissue, 20.0 sq cm or less	122	311	$91
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	253	1,478	$90
99238	Hospital discharge day management, 30 minutes or less	172	182	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	304	804	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	40	1,579	$31,068
Vancomycin Hcl	Vancomycin Hcl	21	171	$4,481
Levothyroxine Sodium	Levothyroxine Sodium	42	3,630	$947
Ceftriaxone	Ceftriaxone Sodium	13	96	$946
Cholestyramine	Cholestyramine (With Sugar)	13	839	$938

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0570	Nebulizer, with compressor	Y	N/R	13	$51

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$201	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Moaddel, M.D.?

Tedicare shows public-source Medicare data for David Moaddel, M.D. (NPI 1376808626), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Moaddel, M.D. have ACO affiliation data?

David Moaddel, M.D. is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342).

What billing organization is linked to David Moaddel, M.D.?

David Moaddel, M.D. is linked to MOADDEL MEDICAL CORPORATION (billing NPI 1780371799) in the available physician profile data.

Does David Moaddel, M.D. have Open Payments data?

David Moaddel, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.